Get the Stockscreener App
8.77
4.16%
0.35
After Hours:
8.81
0.04
+0.46%
Immunitybio Inc Stock (IBRX) Forecast
The Immunitybio Inc (IBRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.8604, representing a -10.37% decrease from the current price of $8.77. The highest analyst price target is $9.4402, and the lowest is $6.2805.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IBRX Price Target
Average 6.2718
(-28.49% Downside)
Is Immunitybio Inc (IBRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.82 | Neutral |
| STOCH(9,6) | 27.42 | Neutral |
| STOCHRSI(14) | 13.70 | Buy |
| MACD(12,26) | 0.1907 | Sell |
| ADX(14) | 35.98 | Sell |
| William %R | -75.56 | Neutral |
| CCI(14) | -101.04 | Sell |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.637
Sell
|
9.357
Sell
|
| MA20 |
9.4253
Sell
|
9.298
Sell
|
| MA50 |
8.6011
Buy
|
8.7926
Sell
|
| MA100 |
8.1122
Buy
|
8.2654
Buy
|
| MA200 |
7.662
Buy
|
7.1227
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, IBRX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 8 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on IBRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.82 indicates that IBRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 27.42 indicates that IBRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.7 indicates that IBRX is oversold. This suggests that IBRX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.98 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -101.04 indicates that IBRX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term IBRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immunitybio Inc financial reports and earnings history, Immunitybio Inc (IBRX) stock could reach $5.1317 by 2030, $4.9197 by 2040 and $8.9533 by 2050. See the projected annual prices until 2050 of the Immunitybio Inc stock below:
- Immunitybio Inc (IBRX) is expected to reach an average price of $4.3876 in 2035, with a high prediction of $6.2668 and a low estimate of $4.1474. This indicates an $-49.97% rise from the last recorded price of $8.77.
- Immunitybio Inc (IBRX) stock is projected to chart a bullish course in 2040, with an average price target of $4.3106, representing an $-50.85% surge from its current level. The forecast ranges from a conservative $3.9706 to a sky-high $4.9197.
- Our analysts predict Immunitybio Inc (IBRX) to jump -16.00% by 2045, soaring from $6.3757 to an average price of $7.3666, potentially reaching $8.606. While $6.3757 is the low estimate, the potential upside is significant.
- Immunitybio Inc (IBRX) stock is expected to climb by 2050, reaching an average of $6.7453, a $-23.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.9533 and $6.6753, respectively, highlighting the market's uncertainty.
Immunitybio Inc Stock (IBRX) Year by Year Forecast
Immunitybio Inc Stock (IBRX) Price Forecast for 2026
The predicted value for Immunitybio Inc (IBRX) in 2026 is set at an average of $7.205. Estimates vary from a peak of $12.43 to a trough of $1.98, indicating an -17.84% surge from the present price of $8.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $7.0005 | $6.2805 | $9.4402 | -20.18% |
| December, 2026 | $7.0409 | $5.6116 | $8.5106 | -19.72% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immunitybio Inc (IBRX) is $5.7972, with a high forecast of $8.491 and a low forecast of $3.1034. This indicates an -33.90% decrease from the last price of $8.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.1713 | $6.3913 | $8.491 | -18.23% |
| February, 2027 | $5.8917 | $5.3115 | $7.2504 | -32.82% |
| March, 2027 | $6.5922 | $5.9018 | $8.3519 | -24.83% |
| April, 2027 | $6.1127 | $5.6025 | $7.3143 | -30.30% |
| May, 2027 | $4.1332 | $4.0032 | $6.7779 | -52.87% |
| June, 2027 | $4.4236 | $3.1034 | $4.9433 | -49.56% |
| July, 2027 | $3.674 | $3.344 | $5.1039 | -58.11% |
| August, 2027 | $5.0045 | $3.6541 | $5.3694 | -42.94% |
| September, 2027 | $5.0249 | $4.0248 | $5.3049 | -42.70% |
| October, 2027 | $4.7953 | $4.2051 | $5.345 | -45.32% |
| November, 2027 | $5.6258 | $4.7054 | $8.3055 | -35.85% |
| December, 2027 | $6.0062 | $5.1959 | $6.5811 | -31.51% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2028
In 2028, Immunitybio Inc (IBRX) is projected to reach an average price of $4.6628, with a high projection of $7.607 and a low estimate of $1.7186. This indicates an -46.83% fall from the last price of $8.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.0167 | $4.8564 | $7.0864 | -31.39% |
| February, 2028 | $5.9671 | $5.7721 | $7.607 | -31.96% |
| March, 2028 | $5.1176 | $4.6674 | $6.0002 | -41.65% |
| April, 2028 | $4.358 | $4.1978 | $5.2577 | -50.31% |
| May, 2028 | $1.9485 | $1.7285 | $4.4281 | -77.78% |
| June, 2028 | $2.1489 | $1.7186 | $2.5238 | -75.50% |
| July, 2028 | $2.7894 | $1.979 | $7.4394 | -68.19% |
| August, 2028 | $3.2798 | $2.7595 | $4.2295 | -62.60% |
| September, 2028 | $3.2902 | $2.9502 | $3.8999 | -62.48% |
| October, 2028 | $2.7107 | $2.6907 | $3.8405 | -69.09% |
| November, 2028 | $2.1611 | $2.1011 | $2.7008 | -75.36% |
| December, 2028 | $2.3115 | $1.7814 | $2.3315 | -73.64% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2029
The 2029 price forecast for Immunitybio Inc Stock (IBRX) is $6.4036 on average, with a high prediction of $11.05 and a low estimate of $1.7619. This represents an -26.98% decrease from the previous price of $8.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.8121 | $1.7619 | $2.3616 | -79.34% |
| February, 2029 | $3.6225 | $1.7922 | $4.5624 | -58.69% |
| March, 2029 | $4.2929 | $3.4526 | $5.0027 | -51.05% |
| April, 2029 | $4.9234 | $3.6131 | $5.7945 | -43.86% |
| May, 2029 | $3.8738 | $3.6337 | $4.9935 | -55.83% |
| June, 2029 | $4.0142 | $3.8842 | $5.7642 | -54.23% |
| July, 2029 | $6.5847 | $4.2643 | $7.2947 | -24.92% |
| August, 2029 | $5.7851 | $5.1048 | $6.845 | -34.04% |
| September, 2029 | $8.6355 | $5.3052 | $11.05 | -1.53% |
| October, 2029 | $6.476 | $6.006 | $9.6756 | -26.16% |
| November, 2029 | $7.1364 | $6.3061 | $8.1462 | -18.63% |
| December, 2029 | $5.057 | $4.637 | $7.2215 | -42.34% |
Immunitybio Inc Stock (IBRX) Price Forecast for 2030
Immunitybio Inc Stock (IBRX) is expected to reach an average price of $5.1748 in 2030, with a high forecast of $7.9982 and a low forecast of $2.3514. This signifies an -40.99% decrease from the last price of $8.77.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.8974 | $3.8474 | $5.1317 | -55.56% |
| February, 2030 | $4.2378 | $3.7476 | $4.5577 | -51.68% |
| March, 2030 | $5.8382 | $3.7119 | $7.9982 | -33.43% |
| April, 2030 | $5.6187 | $4.9486 | $7.3383 | -35.93% |
| May, 2030 | $3.1391 | $3.1291 | $5.9488 | -64.21% |
| June, 2030 | $2.9395 | $2.8995 | $3.4945 | -66.48% |
| July, 2030 | $4.14 | $2.7996 | $4.4488 | -52.79% |
| August, 2030 | $3.3904 | $3.2504 | $4.7901 | -61.34% |
| September, 2030 | $3.1509 | $2.871 | $3.9906 | -64.07% |
| October, 2030 | $3.0613 | $2.911 | $3.556 | -65.09% |
| November, 2030 | $3.1818 | $2.3514 | $3.5767 | -63.72% |
| December, 2030 | $3.1623 | $3.1419 | $4.282 | -63.94% |
4.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):